Private Capital Group, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$12,000
-20.0%
2060.0%0.01%
+200.0%
Q1 2022$15,000
-16.7%
206
-1.0%
0.00%
-25.0%
Q4 2021$18,000
-5.3%
208
+1.0%
0.00%0.0%
Q3 2021$19,000
-5.0%
206
-1.0%
0.00%
-20.0%
Q2 2021$20,000
-16.7%
208
-3.3%
0.01%
-16.7%
Q1 2021$24,000
-68.0%
215
-60.2%
0.01%
-57.1%
Q4 2020$75,000
+70.5%
540
-0.2%
0.01%
+55.6%
Q3 2020$44,000
+7.3%
541
+2.5%
0.01%0.0%
Q2 2020$41,000
+78.3%
528
+3.9%
0.01%
+50.0%
Q1 2020$23,000
+64.3%
508
+52.1%
0.01%
+100.0%
Q4 2019$14,000
+600.0%
334
+882.4%
0.00%
Q3 2019$2,000
-33.3%
340.0%0.00%
-100.0%
Q2 2019$3,000
+50.0%
340.0%0.00%
Q1 2019$2,000
+100.0%
340.0%0.00%
Q4 2018$1,000
-50.0%
340.0%0.00%
Q3 2018$2,0000.0%340.0%0.00%
Q2 2018$2,0000.0%340.0%0.00%
Q1 2018$2,0000.0%34
-97.7%
0.00%
Q4 2017$2,0001,5000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2017
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders